Photo taken from Shushan Hovsepyan/LinkedIn
Mar 29, 2024, 18:54
Shushan Hovsepyan: Exploring new drugs for ultra-rare cancers?
Shushan Hovsepyan, Pediatric Oncologist and Research Coordinator at Yeolyan Hematology and Oncology Center, posted on X/Twitter:
“Exploring new drugs for ultra-rare cancers? Take ASPS: only 60 cases/year in Europe and just 2 major studies. There is an urgent need for collaboration among researchers, patient groups, industry, and regulators. More in Journal of Clinical Oncology.”
Source: Shushan Hovsepyan/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 27, 2024, 01:25
Dec 27, 2024, 01:25
Dec 26, 2024, 22:47
Dec 26, 2024, 22:34
Dec 26, 2024, 16:40
Dec 26, 2024, 16:31